The clock is ticking for Alex Rodriguez, as MLB is soon expected to announce a suspension for his alleged involvement with Biogenesis. But it could be unlike anything we were expecting.
According to the Associated Press, MLB could suspend Rodriguez under the collective bargaining agreement rather than the regular drug rules. This is potentially huge, as it would prevent him from playing if he appeals a suspension. Here’s what MLB could be thinking.
While use of banned performance-enhancing substances falls under the drug agreement, MLB may argue other alleged violations are punishable under the labor contract, a person familiar with management’s deliberations told the AP, speaking on condition of anonymity because no statements were authorized.
Taking that action would prevent the New York Yankees third baseman from returning to the field, even if he recovers from a quadriceps injury cited by the team as the reason for keeping him on the disabled list.
And merely threatening to use that provision might give MLB leverage to force a deal.
The report states that Rodriguez could be banned under Article XII B of the Basic Agreement, which states: “Players may be disciplined for just cause for conduct that is materially detrimental or materially prejudicial to the best interests of baseball including, but not limited to, engaging in conduct in violation of federal, state or local law.”
Yes, the “best interests of baseball” clause. If Rodriguez is suspended under that section, he would serve the penalty while a grievance is litigated. And as we heard from A-Rod’s lawyer earlier today, they have every intention to fight. The union would almost certainly fight it tooth and nail too, even if the evidence against Rodriguez is extensive. If they don’t, the drug agreement is basically rendered worthless. And you thought this was ugly before? We could be looking at a protracted and messy legal battle here.
The Giants have acquired All-Star infielder Eduardo Nunez from the Twins in exchange for minor league pitcher Adalberto Mejia, the club announced on Thursday night.
Nunez, 29, went 0-for-4 in Thursday night’s game against the Orioles. He’s hitting .296/.325/.439 with 12 home runs, 47 RBI, 49 runs scored, and a league-best 26 stolen bases in 391 plate appearances this season. Nunez has played mostly at shortstop this season, but has also logged significant time at third base and a handful of games at second base, so he’ll give the Giants some versatility.
Nunez will likely play a lot of third base for the Giants as Matt Duffy is still sidelined with a strained left Achilles. He’s earning $1.475 million this season and will enter his third and final year of arbitration eligibility heading into 2017.
Mejia, 23, was considered the Giants’ seventh-best prospect by MLB Pipeline. He earned a promotion to Triple-A Sacramento last month after posting a 1.94 ERA with Double-A Richmond. In seven starts with Sacramento, he has a 4.20 ERA with a 43/11 K/BB ratio in 40 2/3 innings.
With a roster spot open, the Twins called up infield prospect Jorge Polanco from Triple-A Rochester, per MLB.com’s Rhett Bollinger.
Bob Nightengale of USA TODAY reports that the Mariners have received “strong” trade interest for starter Taijuan Walker. The right-hander is currently on the mend from tendinitis in his right foot. He’ll throw a bullpen on Friday at Wrigley Field with scouts in attendance.
Walker, 23, has a 3.66 ERA with an 80/18 K/BB ratio in 86 innings this season. It’s his first bit of sustained success at the major league level. What’s arguably just as intriguing is the fact that Walker will be under team control through 2020.
The Mariners have been hovering around .500 for the last month and entered Thursday six games behind the first-place Rangers in the AL West and 4.5 games out of the second AL Wild Card slot, behind three other teams as well as the two Wild Card leaders. It’s enough uncertainty which could push the Mariners to sell.